ArticleAdvanced healthcare materials2026
Electroactive Sodium Alginate-Based Hydrogel Textile for Synergistic Antibacterial and Regenerative Therapy in Diabetic Wound.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Diabetic wound healing poses a significant clinical challenge due to high blood glucose, infection susceptibility, and impaired regeneration. However, current film-based hydrogel dressings often have limited gas permeability that restricts oxygen diffusion and may cause inflammation with prolonged use. This investigation presents an electroactive sodium alginate (SA)-based hydrogel textile through the synergistic effect of tannic acid (TA)-mediated carbon nanotubes (CNTs) dispersion and antibacterial properties. The dressing exhibits a skin-mimicking electrical conductivity of 0.107 S/m and remarkable broad-spectrum antibacterial activity, achieving an inhibition rate of over 99% against both Escherichia coli (E. coli) and methicillin-resistant Staphylococcus aureus (MRSA). Significantly, its antibacterial effect is achieved without relying on photothermal effects or antibiotic release, effectively avoiding thermal injury and drug resistance risks. In vivo experiments demonstrate that the hydrogel dressing can notably decrease the level of the pro-inflammatory cytokine IL-1β at the wound site, stimulate collagen deposition, and accelerate epithelialization. As a result, it enables over 99% closure of diabetic wounds within 18 days. This woven dressing provides a promising new design and preparation strategy, holding great potential for improving the clinical treatment of diabetic wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.